About Us

Our History

PerceptiMed was first venture funded in early 2013 with a driving purpose — to reduce the margin of human error in prescription pill dispensing in retail pharmacies, long-term care facilities and hospitals.

Our proprietary VeriFill™ system includes the industry’s only vision technology capable of identifying imprints on pills. Our IdentRx™ suite of automated medication verification and dispensing products leverage that technology to provide 100% verification of every single pill dispensed. Regardless of size or shape of pill, or method of imprint.

Ensuring the right prescription makes it into the hands of the right patient is also a priority. Our unique ScripClip™ bag clips easily work within any pharmacy set up to identify each and every bag.

As a result, patients can rest assured that the medication and dosage they were prescribed, are in fact the medication and dosage they are receiving.

Leadership

Dan-Gordon-2019-CQ-300x300-121

Dan Gordon

President

Dan brings over 30 years of various business experience ranging from healthcare private capital management to consulting, revenue cycle management, and advertising. He has held roles in business development, strategy, customer experience, product management, organizational development, sales, marketing, and mergers and acquisitions. He has also started, operated and sold several businesses.

Dan is a sought-after keynote speaker, author and frequent contributor of thought leadership on customer experience and employee experience at numerous industry events. He is a founding member of the Omaha Customer Experience Professionals Association, and he has consulted with various organizations on corporate strategy, organizational development and business development. He is a graduate from the University of Notre Dame with a degree in Finance and Business Economics and a minor in Psychology. In addition to being a fitness junkie, Dan spends his free time with his wife chasing their three boys around the country to watch their collegiate sporting events.

Frank-Maione-200x200-2021

Frank Maione

Chief Business Officer

With over 38 years of experience working in the consumer package goods (CPG) industry, Frank brings considerable expertise in sales, marketing and logistics to his new position as Chief Business Officer at InterLink AI. He also brings hands-on customer knowledge and relationships across the pharma and retail markets.

Previously, Frank was president of Frank Maione Consulting, where he specialized in operations and sales strategy and development, brand reinvention, new product launches, optimizing integration and business pivots. Prior to this, Frank served as president and chief customer officer Johnson and Johnson (JNJ) Consumer Sales and Logistics, USA. While here, Frank built a 500+ sales team, generating $7.5B annually via sales strategies crafted for Walmart, Target, CVS, Walgreens and Costco, among others. Frank joined JNJ with its acquisition of Pfizer Consumer Brands in 2007. At the time, Frank was vice president of sales for Pfizer, where he created a customer centric mind shift that elevated consumer sales from a sixth overall industry ranking to number one. In recognition for his efforts, Frank was honored with the President’s Innovation Award (2003) and the President’s Leadership Award (2005). He was also tasked with leading the sales integration of Pfizer into JNJ. Frank began his career at the retail rep level for Warner Lambert in 1976. He has a Bachelor’s of Science degree from California Coast University.

stephen-hug-bio-headshot

Stephen Hug

Chief Financial Officer

Stephen Hug is the chief financial officer at InternlinkAI. Stephen is a versatile leader who brings more than 30 years of experience in leadership, strategy and product management, and finance.

Since December 2019, Stephen has served as the Entrepreneur in Resident at the University of Nebraska Medical Center UNeTech Institute, a university start up incubator, where he supports and mentors university researchers, inventors, and entrepreneurs in product develop and commercialization.

Prior to UNMC, Stephen had a successful career at First Data (now Fiserv), a financial services technology provider serving financial institutions, retailers, and technology providers. Stephen had roles in finance, strategy, product management, and business leadership. In his last role, Stephen served as business leader and product manager responsible for First Data’s Financial Services North America processing business generating more $500 million in annual revenue.

Stephen holds a Bachelor of Science in Business Administration with an emphasis in Finance from the University of Nebraska at Omaha.

Stephen serves on the Board of Directors at Metro Omaha Medical Society Foundation and provides volunteer advisory support to emerging businesses, entrepreneurs, and nonprofits.

Terry-Carter-200x200-2021

Terry Cater

Vice President of Business Development & Marketing

Terry Cater has been an independent pharmacy and healthcare consultant and a veteran of the pharmacy industry. He has decades of experience in management of pharmacies in large, publicly traded corporations, as well as numerous startups and independent pharmacies. He was a Director of Pharmacy at Safeway and Save Mart. He was also a Vice President at both McKesson Corporation and Cardinal Health. Terry is a registered Pharmacist in the states of California, Nevada and Hawaii. He is a member of the California Pharmacists Associations and the National Community Pharmacists Association. He has served on many advisory boards. Terry has extensive experience in start-up company management.

Terry received his Bachelor of Science in Pharmacy from the University of the Pacific and his M.B.A. at Saint Mary’s College of California.

rob_thomas_res2

Rob Thomas

Chief Technology Officer
Rob Thomas is a global IT Senior Executive with over 20 years’ experience in building and executing strategic plans with innovative, best-in-class technology solutions. He is skilled in the fields of software development, innovative technology, and information strategy.

Throughout his experiences as an IT executive, Rob has had the pleasure to work for a large Non-Profit organization in Kansas City which has given him an unparalleled perspective of leading a large, multi-faceted international team. He led the largest technical overhaul their 60-year history, impacting over 400 global locations and expanding the technical proficiencies of over 1,800 employees internationally.

In addition to Rob’s experiences in the Non-Profit realm, he founded Peerhouse, an IT consulting firm, which includes such former clients as McDonald’s Corporate, Dell Computers, US Air Force, Academy Bank, among others. Rob received his Bachelor of Science in Business and Finance/Human Resources from the University of Nebraska-Lincoln.

Jim-Mack-200x200-2021

Jim Mack

Vice President of Customer Service

Jim has years of experience with leadership in building and developing customer-oriented teams and managing programs for technical & customer support, field service, implementation, training and professional services. He has been: a Technical Support Manager at Intuitive Surgical, Inc., a Program Manager for certification and training at Varian Medical Systems, and a Director of Technical Support at Bytemobile, Inc. in Mountain View, CA. Jim has experience in both small and large companies.

Jim holds a B.S.E.E. in Electrical Engineering from the University of Massachusetts, Amherst.

Our Board of Directors

Rod-Markin-Headshot-200x200-2021[79]

Rodney S. Markin, Chairman​

Associate Vice Chancellor of Business Development and Professor of Pathology & Microbiology at the University of Nebraska Medical Center

Rodney S. Markin previously spent 12 years as the Chairman, President and CEO of UNMC Physicians and served as the Interim Dean of the College of Medicine at UNMC. Dr. Markin’s professional and academic research interests have focused on clinical laboratory automation, which include but are not limited to, robotics, information systems, medical utilization management and outcomes optimization.

Dr. Markin received his Bachelor’s Degree in chemistry with a minor in mathematics and physics from Nebraska Wesleyan University in 1977; his Doctor of Philosophy (Ph.D.- biochemistry) from the University of Nebraska-Lincoln in 1980; his Doctor of Medicine (M.D.) degree from the University of Nebraska Medical Center (Omaha) in 1983. Dr. Markin completed his residency in pathology and laboratory medicine at the University of Nebraska Medical Center. Dr. Markin is board certified in Anatomic and Clinical Pathology.

Dr. Markin founded LAB-InterLink, a spin-out of the University of Nebraska Medical Center that provided products for hospital-based laboratory automation systems. He served as CEO of the company and provided the early funding to grow the business.

Tom-Lavin-200x200-2021

Tom Lavin, Chairman​

Vice President of Business Development & Marketing
Partner & Chief Financial Officer, New Science Ventures


Tom Lavin is a co-founder of New Science Ventures and its Chief Financial Officer, responsible for financial, legal and administrative matters. He serves on the Board of Directors for Achronix Semiconductor Corporation, Light Sciences Oncology, and RF Arrays, Inc. and is an observer on the boards of Vorago, Juventas Therapeutics, Therox and Directed Sensing. He formerly served on the Board of Celleration (acquired by Aliqua). Prior to NSV, he was a senior professional in finance and investment banking for over 30 years. Tom has extensive experience in private and public equity and debt transactions, mergers and acquisitions and financial restructurings in the U.S. and abroad. He was head of real estate investment banking at First Boston and Smith Barney and head of commercial mortgage lending at MetLife. Tom holds an A.B. degree in Government from Wesleyan University and an M.B.A. from Harvard Business School.

Bob-Curry-200x200-202166

Bob Curry

Board Member

Bob has 32 years of healthcare venture capital investing experience including active involvement with 38 start-up or early stage companies, of which 32 achieved an IPO or successful merger. Prior to his VC activities, Bob started two companies of his own, one of which was a diagnostics lab and the other was a diagnostic product company. Bob also held an academic professorship at the University of Delaware, as well as being the Director of Technology at Becton Dickinson.

Prior to joining Latterell Venture Partners, Bob was a partner at Alliance Technology Ventures where he invested exclusively in healthcare ventures. Before ATV he was the original healthcare partner at the Sprout Group (the venture affiliate of Donaldson, Lufkin & Jenrette), and prior to Sprout he was the President of Merrill Lynch Venture Capital and Merrill Lynch R&D Management Inc. He also has served for many years as the Board Chair at the Keck Graduate Institute of Applied Life Sciences at the Claremont Colleges.

Bob holds a Ph.D. and an M.S. in chemistry from Purdue University where he was a Smith Kline Fellow, and he received his B.S. in physics from the University of Illinois at Urbana where he was a James Scholar.

Jim-Woody-200x200-2021

Jim Woody​

Partner, Latterell Venture Partners

Jim brings more than 25 years of pharmaceutical research and management experience to LVP. In addition to his duties at LVP, Jim is currently chairman of Oncomed Pharmaceuticals, where he previously served as the founding CEO and helped organize the formation of the company. Jim was formerly President of Roche Bioscience in Palo Alto, CA. where he had responsibility for all bioscience research and development, ranging from genetics and genomics to clinical development of numerous new pharmaceuticals. Previously, Jim served as Chief Scientific Officer and Senior Vice President of R & D for Centocor, where he was responsible for the discovery and early clinical development of antibody and peptide-based therapeutic products. While at Centocor, Jim developed Remicade, the first of the TNF inhibitor biologics, as well as ReoPro, a novel platelet blocking drug used in conjunction with angioplasty.

Prior to Centocor, Jim served as Commanding Officer and Director, US Naval Medical Research and Development Command in Bethesda Maryland. In that role, he was responsible for a wide range of medical research and development activities ranging from transplantation research to infectious diseases. He was responsible for the surveillance, detection and therapy for all Biologic Warfare Agents and Infectious Diseases in the first Gulf War, and was awarded the US Navy Legion of Merit for his service.

Jim holds an M.D. from Loma Linda University, trained in Pediatric Immunology at Duke University and Children’s Hospital in Boston (Harvard), and holds a Ph.D. in Immunology from the University of London, England. Jim has authored or co-authored over 140 publications.